Cervix HPV Vaccine Effective in Older Women

New Hope for Preventing Cervical Cancer in Women Up to 55

GlaxoSmithKline, the maker of the yet FDA approved HPV vaccine Cervarix, has released promising results about the vaccine. The results showed Cervarix to be 100 percent effective in young girls and women ages 9-55. This is compared to rival vaccine, Gardasil, which is effective in girls and young women ages 9-26.

Like Gardasil, Cervarix is a three dose vaccine given over a six month period. It has already been approved in Australia, and is currently under review by the FDA.

More About HPV:

• What is HPV?
  
• How Do You Get HPV?
  
• How to Find Out if You Have HPV
  
• Do Men Get HPV
  
• HPV Treatment

_{Photo (c)Mark Csaibai}